Clinuvel Pharmaceuticals buy t66wv33c
Start price
07.02.19
/
50%
€14.29
Target price
03.05.19
€22.55
Performance (%)
6.37%
End price
03.05.19
€15.20
Summary
This prediction ended on 03.05.19 with a price of €15.20. With a performance of 6.37%, the BUY prediction by t66wv33c for Clinuvel Pharmaceuticals closed with a slight gain. t66wv33c has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Clinuvel Pharmaceuticals | -1.883% | -1.883% | -11.435% | -54.626% |
| iShares Core DAX® | -1,74 % | 5,98 % | 8,98 % | 49,86 % |
| iShares Nasdaq 100 | 2,81 % | 11,83 % | 38,41 % | 100,33 % |
| iShares Nikkei 225® | -0,11 % | 11,69 % | 46,68 % | 65,35 % |
| iShares S&P 500 | 0,97 % | 7,62 % | 28,14 % | 68,66 % |
Comments by t66wv33c for this prediction
In the thread Clinuvel Pharmaceuticals diskutieren
Hoffnung auf Zulassung von EPP in USA
Einziger Hersteller - in Europa schon erfolgreich zugelassen!
(Vom Mitglied beendet)
Stopped prediction by t66wv33c for Clinuvel Pharmaceuticals
Clinuvel Pharmaceuticals
Start price
Target price
Perf. (%)
€15.23
03.05.19
03.05.19
€19.30
17.05.19
17.05.19
26.72%
17.05.19
17.05.19


